The global RSV community will gather in Santiago de Compostela from 14 to 17 April 2027 for the 14th International Respiratory Syncytial Virus (RSV) Symposium, chaired by Federico Martinón-Torres. As one of the leading figures in paediatric infectious diseases and vaccine research, Professor Martinón-Torres brings both scientific authority and strategic vision to this flagship event organised by the iRSV Society.
Federico Martinón-Torres Chair of the 14th International Respiratory Syncytial Virus (RSV) Symposium
Widely recognised for his work in advancing RSV immunisation strategies across high-, middle-, and low-income settings, Professor Martinón-Torres has played a pivotal role in shaping prevention efforts at a global level. His leadership is expected to ensure that the 2027 Symposium delivers both scientific depth and meaningful international collaboration.
The four-day meeting will convene leading researchers, clinicians, and public health experts to explore the latest developments in RSV and other respiratory viruses. The program will feature thematic sessions combining keynote presentations with short oral communications selected from submitted abstracts, alongside a formal poster session. A dedicated RSV Mini School on 13 April will provide additional learning opportunities ahead of the main conference, while structured networking time throughout the event will support collaboration across disciplines.
The Symposium will also highlight excellence in the field through prestigious lectures, including the José Antonio Melero Early Career Investigator Award and the Chanock Award.
Professor Martinón-Torres currently serves as Head of Pediatrics and Director of Translational Pediatrics and Infectious Diseases at the Hospital Clínico Universitario de Santiago, and is a Full Professor at the University of Santiago de Compostela. He leads the GENVIP research group and contributes to global health policy through his role with the WHO European Technical Advisory Group of Experts, as well as coordinating a WHO Collaborating Centre for Vaccine Safety.
With his extensive expertise spanning RSV, vaccines, and infectious diseases, Professor Martinón-Torres is well positioned to guide a Symposium that will shape the future direction of RSV research and prevention worldwide.
Further reading
